Fasiglifam, TAK-875
Nkọwa ngwaahịa
Mkpado ngwaahịa
| Nha ngwugwu | Nnweta | Ọnụ ego (USD) |
Aha kemịkalụ:
(S) -2- (6- ((2',6'-dimethyl-4'-- (3- (methylsulfonyl) propoxy)-[1,1'-biphenyl] -3-yl) methoxy) -2,3 Dihydrobenzofuran-3-yl) acetic acid
Koodu Ọchịchọ:
O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3 )=CC=C12
Koodu InChi:
InChi=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21 14-22)17-35-24-8-9-2 6-23 (15-28 (30) 31) 18-36-27 (26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2, 1-3H3, (H,30,31)/t23-/m1/s1
Igodo InChi:
BZCALJIHZVNMGJ-HSZRJFAPSA-N
Okwu:
1000413-72-8;CAS:1000413-72-8;CAS:1000413-72-8;TAK875;TAK-875;TAK 875Fasiglifam
Solubility:Soluble na DMSO, ọ bụghị na mmiri
Nchekwa:0 - 4 C maka obere oge (ụbọchị ruo izu), ma ọ bụ -20 C maka ogologo oge (ọnwa).
Nkọwa:
Fasiglifam (TAK-875) bụ agonist GPR40 dị irè, ọnụ na nhọrọ.
Ebumnuche: GPR40 agonist
